Literature DB >> 20570913

Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.

Linda E Kelemen1, Marc T Goodman, Valerie McGuire, Mary Anne Rossing, Penelope M Webb, Martin Köbel, Hoda Anton-Culver, Jonathan Beesley, Andrew Berchuck, Sony Brar, Michael E Carney, Jenny Chang-Claude, Georgia Chenevix-Trench, Daniel W Cramer, Julie M Cunningham, Richard A Dicioccio, Jennifer A Doherty, Douglas F Easton, Zachary S Fredericksen, Brooke L Fridley, Margaret A Gates, Simon A Gayther, Aleksandra Gentry-Maharaj, Estrid Høgdall, Susanne Krüger Kjaer, Galina Lurie, Usha Menon, Patricia G Moorman, Kirsten Moysich, Roberta B Ness, Rachel T Palmieri, Celeste L Pearce, Paul D P Pharoah, Susan J Ramus, Honglin Song, Daniel O Stram, Shelley S Tworoger, David Van Den Berg, Robert A Vierkant, Shan Wang-Gohrke, Alice S Whittemore, Lynne R Wilkens, Anna H Wu, Joellen M Schildkraut, Thomas A Sellers, Ellen L Goode.   

Abstract

BACKGROUND: We previously reported the risks of ovarian carcinoma for common polymorphisms in one-carbon transfer genes. We sought to replicate associations for DPYD rs1801265, DNMT3A rs13420827, MTHFD1 rs1950902, MTHFS rs17284990, and TYMS rs495139 with risk of ovarian carcinoma overall and to use the large sample of assembled cases to investigate associations by histologic type.
METHODS: Associations were evaluated in the Ovarian Cancer Association Consortium, including 16 studies of 5,593 epithelial ovarian carcinoma cases and 9,962 controls of white non-Hispanic origin. Odds ratios (OR) and 95% confidence intervals (CI) were adjusted for age and study site.
RESULTS: The five polymorphisms were not associated with ovarian carcinoma overall (P(trend) > 0.13); however, associations for the minor allele at TYMS rs495139 were observed for carcinomas of mucinous type (OR, 1.19; 95% CI, 1.03-1.39; P = 0.02), clear cell type (OR, 0.86; 95% CI, 0.75-0.99; P = 0.04), and endometrioid type (OR, 0.90; 95% CI, 0.81-0.99; P = 0.04; P(heterogeneity) = 0.001). Restriction to low-grade mucinous carcinomas further strengthened the association for the mucinous type (OR, 1.32; 95% CI, 1.07-1.62; P = 0.01). TYMS rs495139 was not associated with serous type (OR, 1.06; 95% CI, 1.00-1.13; P = 0.05).
CONCLUSIONS: TYMS rs495139 may be associated with a differential risk of ovarian carcinoma types, indicating the importance of accurate histopathologic classification. IMPACT: Biomarkers that distinguish ovarian carcinoma types are few, and TYMS rs495139 may provide a novel clue to type etiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570913      PMCID: PMC3013232          DOI: 10.1158/1055-9965.EPI-09-1317

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases.

Authors:  M Cuatrecasas; A Villanueva; X Matias-Guiu; J Prat
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

2.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

3.  Consortium analysis of 7 candidate SNPs for ovarian cancer.

Authors:  Susan J Ramus; Robert A Vierkant; Sharon E Johnatty; Malcolm C Pike; David J Van Den Berg; Anna H Wu; Celeste Leigh Pearce; Usha Menon; Aleksandra Gentry-Maharaj; Simon A Gayther; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Honglin Song; Douglas F Easton; Paul D P Pharoah; Montserrat Garcia-Closas; Stephen Chanock; Jolanta Lissowska; Louise Brinton; Kathryn L Terry; Daniel W Cramer; Shelley S Tworoger; Susan E Hankinson; Andrew Berchuck; Patricia G Moorman; Joellen M Schildkraut; Julie M Cunningham; Mark Liebow; Susanne Krüger Kjaer; Estrid Hogdall; Claus Hogdall; Jan Blaakaer; Roberta B Ness; Kirsten B Moysich; Robert P Edwards; Michael E Carney; Galina Lurie; Marc T Goodman; Shan Wang-Gohrke; Silke Kropp; Jenny Chang-Claude; Penelope M Webb; Xiaoqing Chen; Jonathan Beesley; Georgia Chenevix-Trench; Ellen L Goode
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

4.  Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?

Authors:  Michael H Roh; David Kindelberger; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

Review 5.  The biology of ovarian cancer: new opportunities for translation.

Authors:  Robert C Bast; Bryan Hennessy; Gordon B Mills
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

6.  Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease.

Authors:  Steven A McCarroll; Alan Huett; Petric Kuballa; Shannon D Chilewski; Aimee Landry; Philippe Goyette; Michael C Zody; Jennifer L Hall; Steven R Brant; Judy H Cho; Richard H Duerr; Mark S Silverberg; Kent D Taylor; John D Rioux; David Altshuler; Mark J Daly; Ramnik J Xavier
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

Review 7.  Ovarian carcinoma pathology and genetics: recent advances.

Authors:  C Blake Gilks; Jaime Prat
Journal:  Hum Pathol       Date:  2009-06-24       Impact factor: 3.466

8.  Association of thymidylate synthase gene with endometrial cancer risk in a Chinese population.

Authors:  Wang-Hong Xu; Ji-Rong Long; Wei Zheng; Zhi-Xian Ruan; Qiuyin Cai; Jia-Rong Cheng; Gen-Ming Zhao; Yong-Bing Xiang; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

9.  Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

Authors:  Martin Köbel; Steve E Kalloger; Niki Boyd; Steven McKinney; Erika Mehl; Chana Palmer; Samuel Leung; Nathan J Bowen; Diana N Ionescu; Ashish Rajput; Leah M Prentice; Dianne Miller; Jennifer Santos; Kenneth Swenerton; C Blake Gilks; David Huntsman
Journal:  PLoS Med       Date:  2008-12-02       Impact factor: 11.069

10.  Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.

Authors:  C L Pearce; A M Near; D J Van Den Berg; S J Ramus; A Gentry-Maharaj; U Menon; S A Gayther; A R Anderson; C K Edlund; A H Wu; X Chen; J Beesley; P M Webb; S K Holt; C Chen; J A Doherty; M A Rossing; A S Whittemore; V McGuire; R A DiCioccio; M T Goodman; G Lurie; M E Carney; L R Wilkens; R B Ness; K B Moysich; R Edwards; E Jennison; S K Kjaer; E Hogdall; C K Hogdall; E L Goode; T A Sellers; R A Vierkant; J M Cunningham; J C Cunningham; J M Schildkraut; A Berchuck; P G Moorman; E S Iversen; D W Cramer; K L Terry; A F Vitonis; L Titus-Ernstoff; H Song; P D P Pharoah; A B Spurdle; H Anton-Culver; A Ziogas; W Brewster; V Galitovskiy; G Chenevix-Trench
Journal:  Br J Cancer       Date:  2009-01-06       Impact factor: 7.640

View more
  14 in total

1.  Reconstructing cancer genomes from paired-end sequencing data.

Authors:  Layla Oesper; Anna Ritz; Sarah J Aerni; Ryan Drebin; Benjamin J Raphael
Journal:  BMC Bioinformatics       Date:  2012-04-19       Impact factor: 3.169

2.  Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.

Authors:  Martin Köbel; Steve E Kalloger; Sandra Lee; Máire A Duggan; Linda E Kelemen; Leah Prentice; Kimberly R Kalli; Brooke L Fridley; Daniel W Visscher; Gary L Keeney; Robert A Vierkant; Julie M Cunningham; Christine Chow; Roberta B Ness; Kirsten Moysich; Robert Edwards; Francesmary Modugno; Clareann Bunker; Eva L Wozniak; Elizabeth Benjamin; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; C Blake Gilks; David G Huntsman; Susan J Ramus; Ellen L Goode
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-23       Impact factor: 4.254

3.  Lack of association between MTHFD1 G401A polymorphism and ovarian cancer susceptibility.

Authors:  Yuling Cui; Yanhua Jing; Zihan Sun
Journal:  Tumour Biol       Date:  2013-11-28

Review 4.  Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research.

Authors:  Jennifer A Doherty; Allan Jensen; Linda E Kelemen; Celeste L Pearce; Elizabeth Poole; Joellen M Schildkraut; Kathryn L Terry; Shelley S Tworoger; Penelope M Webb; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2017-10-01       Impact factor: 13.506

5.  Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.

Authors:  Jennifer B Permuth; Ailith Pirie; Y Ann Chen; Hui-Yi Lin; Brett M Reid; Zhihua Chen; Alvaro Monteiro; Joe Dennis; Gustavo Mendoza-Fandino; Hoda Anton-Culver; Elisa V Bandera; Maria Bisogna; Louise Brinton; Angela Brooks-Wilson; Michael E Carney; Georgia Chenevix-Trench; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Cezary Cybulski; Aimee A D'Aloisio; Jennifer Anne Doherty; Madalene Earp; Robert P Edwards; Brooke L Fridley; Simon A Gayther; Aleksandra Gentry-Maharaj; Marc T Goodman; Jacek Gronwald; Estrid Hogdall; Edwin S Iversen; Anna Jakubowska; Allan Jensen; Beth Y Karlan; Linda E Kelemen; Suzanne K Kjaer; Peter Kraft; Nhu D Le; Douglas A Levine; Jolanta Lissowska; Jan Lubinski; Keitaro Matsuo; Usha Menon; Rosemary Modugno; Kirsten B Moysich; Toru Nakanishi; Roberta B Ness; Sara Olson; Irene Orlow; Celeste L Pearce; Tanja Pejovic; Elizabeth M Poole; Susan J Ramus; Mary Anne Rossing; Dale P Sandler; Xiao-Ou Shu; Honglin Song; Jack A Taylor; Soo-Hwang Teo; Kathryn L Terry; Pamela J Thompson; Shelley S Tworoger; Penelope M Webb; Nicolas Wentzensen; Lynne R Wilkens; Stacey Winham; Yin-Ling Woo; Anna H Wu; Hannah Yang; Wei Zheng; Argyrios Ziogas; Catherine M Phelan; Joellen M Schildkraut; Andrew Berchuck; Ellen L Goode; Paul D P Pharoah; Thomas A Sellers
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

6.  Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

Authors:  Linda E Kelemen; Kathryn L Terry; Marc T Goodman; Penelope M Webb; Elisa V Bandera; Valerie McGuire; Mary Anne Rossing; Qinggang Wang; Ed Dicks; Jonathan P Tyrer; Honglin Song; Jolanta Kupryjanczyk; Agnieszka Dansonka-Mieszkowska; Joanna Plisiecka-Halasa; Agnieszka Timorek; Usha Menon; Aleksandra Gentry-Maharaj; Simon A Gayther; Susan J Ramus; Steven A Narod; Harvey A Risch; John R McLaughlin; Nadeem Siddiqui; Rosalind Glasspool; James Paul; Karen Carty; Jacek Gronwald; Jan Lubiński; Anna Jakubowska; Cezary Cybulski; Lambertus A Kiemeney; Leon F A G Massuger; Anne M van Altena; Katja K H Aben; Sara H Olson; Irene Orlow; Daniel W Cramer; Douglas A Levine; Maria Bisogna; Graham G Giles; Melissa C Southey; Fiona Bruinsma; Susanne K Kjaer; Estrid Høgdall; Allan Jensen; Claus K Høgdall; Lene Lundvall; Svend-Aage Engelholm; Florian Heitz; Andreas du Bois; Philipp Harter; Ira Schwaab; Ralf Butzow; Heli Nevanlinna; Liisa M Pelttari; Arto Leminen; Pamela J Thompson; Galina Lurie; Lynne R Wilkens; Diether Lambrechts; Els Van Nieuwenhuysen; Sandrina Lambrechts; Ignace Vergote; Jonathan Beesley; Peter A Fasching; Matthias W Beckmann; Alexander Hein; Arif B Ekici; Jennifer A Doherty; Anna H Wu; Celeste L Pearce; Malcolm C Pike; Daniel Stram; Jenny Chang-Claude; Anja Rudolph; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo B Runnebaum; Natalia Bogdanova; Natalia Antonenkova; Kunle Odunsi; Robert P Edwards; Joseph L Kelley; Francesmary Modugno; Roberta B Ness; Beth Y Karlan; Christine Walsh; Jenny Lester; Sandra Orsulic; Brooke L Fridley; Robert A Vierkant; Julie M Cunningham; Xifeng Wu; Karen Lu; Dong Liang; Michelle A T Hildebrandt; Rachel Palmieri Weber; Edwin S Iversen; Shelley S Tworoger; Elizabeth M Poole; Helga B Salvesen; Camilla Krakstad; Line Bjorge; Ingvild L Tangen; Tanja Pejovic; Yukie Bean; Melissa Kellar; Nicolas Wentzensen; Louise A Brinton; Jolanta Lissowska; Montserrat Garcia-Closas; Ian G Campbell; Diana Eccles; Alice S Whittemore; Weiva Sieh; Joseph H Rothstein; Hoda Anton-Culver; Argyrios Ziogas; Catherine M Phelan; Kirsten B Moysich; Ellen L Goode; Joellen M Schildkraut; Andrew Berchuck; Paul D P Pharoah; Thomas A Sellers; Angela Brooks-Wilson; Linda S Cook; Nhu D Le
Journal:  Mol Nutr Food Res       Date:  2014-07-28       Impact factor: 5.914

7.  Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.

Authors:  Heidrun Karlic; Roman Thaler; Christopher Gerner; Thomas Grunt; Katharina Proestling; Florian Haider; Franz Varga
Journal:  Cancer Genet       Date:  2015-03-18

8.  Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis.

Authors:  Hongtuan Zhang; Hui Ma; Liang Li; Zhihong Zhang; Yong Xu
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

9.  Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.

Authors:  Linda E Kelemen; Elisa V Bandera; Kathryn L Terry; Mary Anne Rossing; Louise A Brinton; Jennifer A Doherty; Roberta B Ness; Susanne Krüger Kjaer; Jenny Chang-Claude; Martin Köbel; Galina Lurie; Pamela J Thompson; Michael E Carney; Kirsten Moysich; Robert Edwards; Clare Bunker; Allan Jensen; Estrid Høgdall; Daniel W Cramer; Allison F Vitonis; Sara H Olson; Melony King; Urmila Chandran; Jolanta Lissowska; Montserrat Garcia-Closas; Hannah Yang; Penelope M Webb; Joellen M Schildkraut; Marc T Goodman; Harvey A Risch
Journal:  BMC Cancer       Date:  2013-01-22       Impact factor: 4.430

10.  Risk-association of DNA methyltransferases polymorphisms with gastric cancer in the Southern Chinese population.

Authors:  Xue-Xi Yang; Xuan-Qiu He; Fen-Xia Li; Ying-Song Wu; Yang Gao; Ming Li
Journal:  Int J Mol Sci       Date:  2012-07-05       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.